What is it about?
Novel antimicrobials are urgently needed to combat the growing problem of antibiotic resistance. This paper describes the antimicrobial activity of NP108 versus antibiotic resistant staphylococci and its other properties that make it a potential alternative to antibiotics for the nasal decolonisation of Staphylococcus aureus and the treatment/prevention of surgical site and other skin infections.
Featured Image
Why is it important?
Antibiotic resistance is a global problem. One strategy to combat antibiotic resistance is the development of novel antimicrobials to replace those antibiotics that are no longer effective. NP108 is a potentially novel alternative to conventional antibiotics for the nasal decolonisation of Staphylococcus aureus and the treatment/prevention of surgical site and other skin infections
Perspectives
I believe that antibiotic resistance is a global issue that need to be addressed by multiple strategies. One such strategy is the design and development of novel antimicrobials for use in place of antibiotics that are no longer effective. I believe that the data generated about NP108, and found in this manuscript, demonstrate that it has potential to be an alternative to antibiotics for the nasal decolonisation of Staphylococcus aureus and the treatment/prevention of surgical site and other skin infections.
Derry Mercer
NovaBiotics Ltd
Read the Original
This page is a summary of: NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, June 2017, ASM Journals,
DOI: 10.1128/aac.00502-17.
You can read the full text:
Contributors
The following have contributed to this page
